About Us

Cardio Diagnostics was founded in 2017 by our Chief Executive Officer, Dr. Meesha Dogan, and our Chief Medical Officer, Dr. Rob Philibert. Well before that, their pioneering work in epigenetics begun over 15 years ago and in artificial intelligence begun over 13 years ago that culminated in the invention of our technology alongside our Chief Technology Officer, Dr. Tim Dogan, who joined as the Company's first employee. The founding team knew that precision cardiovascular medicine driven by epigenetics and artificial intelligence had the power to transform the cardiovascular care continuum and profoundly impact the fight against cardiovascular disease. Cardiovascular disease has been a leading cause of death for over 100 years, and the clinical care for cardiovascular disease has relied on proxy biomarkers, and cost prohibitive, non-scalable and one-size-fits-all solutions. The urgency to alter the trajectory of cardiovascular disease globally cannot be understated. For us, this calling is deeply personal.    
 
By harnessing vast amounts of data, we invented a novel technology at the intersection of genetics, epigenetics and artificial intelligence, capable of providing actionable insights at various stages of clinical care through simple, highly scalable blood tests that can be easily performed. We also knew that becoming the standard of care would also require the buy-in from key healthcare stakeholders such as payers and employers because healthcare decisions are not exclusively made in a clinical setting. As a result, we have built a suite of solutions for both clinical and non-clinical decision makers in healthcare, so they have critical insights to more confidently inform the decisions they make every day. Together, we are charting a deliberate path to be at the forefront of the fight against heart disease, striving for a future where enhanced quality of life is a reality for all.